The US company provides decision support tools in financial, portfolio risk and performance analyzes. Its share is experiencing growth since the beginning of the year by almost 50% and the USD 71.87 resistance is in line of sight.

This company benefit from strong fundamentals as exposed by good Surperformance ratings. It sales should amounted to one billion dollars in 2015 estimation, an increase of 8%. The margin remains very comfortable to over 20% expected for 2015 and 2016. In addition, Thomson Reuters has revised upwards in recent months the forecast earnings per share for the current fiscal year, which leaves a potential on the stock market.

From a technical point of view, the share operates in an upward trend since mid-September. The proper orientation of the moving averages as support does not glimpse of trend reversal in the coming sessions. This growth should help to reach soon the USD 71.87 long term resistance and then the trendline.

The various elements set will allow investors to benefit from the upward trend of MSCI. A long position should be initiated towards USD 71.85 and a crossing of the latter should allow the stock to test the upward slant in the USD 77 area. A return below the 20-day moving average will invalidate our strategy.